IL13 and helminthiasis: A precise understanding of the molecular signaling mechanisms suggests that targeting IL-13, while equally effective, preserves IL-4 signaling through the type-2 IL-4 receptor which may constitute an important safety benefit regarding immunity, especially to helminth infections.